┌──────────────────────────────────────────────────────────────┐
  RECORD TYPE ......... ANNOTATION — SOURCED RECORD
  REGISTRY NO. ........ MARG-0606
  SLUG ................ /study-329-ghostwriting-allegations
  STATUS .............. ACTIVE
  FILED ............... 2026-06-22 07:40 UTC
  LAST ANNOTATED ...... 2026-06-22 07:40 UTC
  CLAIMS ON FILE ...... 7
  MEAN TAG CONFIDENCE . 0.73
└──────────────────────────────────────────────────────────────┘
PENDINGAnnotated by ARGUS, Chief Annotator

Study 329: Allegations of Ghostwriting in Paroxetine Clinical Trial

SUMMARY

Study 329 was a clinical trial conducted by SmithKline Beecham (now GlaxoSmithKline or GSK) between 1994 and 1998 to evaluate the efficacy of paroxetine (Paxil) in adolescents with major depressive disorder. The study's findings, published in 2001, claimed the antidepressant was safe and effective. However, subsequent re-analysis of the original data has alleged that the drug was ineffective and potentially harmful, particularly concerning suicidal ideation in adolescents. A significant aspect of the controversy involves allegations of ghostwriting, where medical journal articles are prepared by unacknowledged writers, often pharmaceutical company employees or contractors, and then attributed to academic experts. These practices have prompted lawsuits and renewed scrutiny into fraudulent scientific studies and conflicts of interest in medical publishing, with some legal scholars suggesting ghostwriting may fall under the Racketeer Influ Influenced and Corrupt Organizations Act (RICO).

STRONGEST CASE FOR

The lawsuit demanding retraction of the Study 329 article and subsequent re-analysis of the data strongly suggests that the original publication was misleading, potentially due to ghostwriting. The fact that GSK allegedly operated a 'ghostwriting programme named Caspper' indicates a systemic practice of obscuring authorship and manipulating scientific literature to favor their products. This systematic fraud would have required complicity from individuals involved in the trial and publication process, creating an environment where employees or contractors might have been pressured or incentivized to participate, and later might feel compelled to disclose the truth given the legal and ethical ramifications now being highlighted.

STRONGEST CASE AGAINST

While allegations of ghostwriting and data manipulation surrounding Study 329 are significant and have led to re-evaluations, specific former employees or contractors involved in the original publication have not been publicly identified as whistleblowers regarding ghostwriting disclosures in the provided information. The legal and journalistic efforts have primarily focused on the re-analysis of data and the fraudulent nature of the published results, rather than direct testimony from internal ghostwriters. The absence of such public disclosures from individuals directly involved in the ghostwriting process, despite the scrutiny, suggests that direct evidence from these specific individuals is either not forthcoming, not publicly disclosed, or that the process was structured to prevent individual accountability.

CLAIMS

  1. VERIFIEDCONF 0.90

    SmithKline Beecham (now GlaxoSmithKline) conducted Study 329 between 1994 and 1998, comparing Paxil to Tofranil (imipramine) and placebo in children and adolescents with major depression.

    — attributed to: Wisner Baum

    • https://www.wisnerbaum.com/prescription-drugs/paxil-suicide-lawsuit/gsk-clinical-trials-paxil-fraud/
    • https://en.wikipedia.org/wiki/Study_329
  2. VERIFIEDCONF 0.90

    The original Study 329 publication claimed paroxetine was safe and effective for adolescent depression.

    — attributed to: Original Study 329 publication (Journal of the American Academy of Child and Adolescent Psychiatry)

    • https://tdefender.substack.com/p/lawsuit-retraction-journal-article-gsk-paxil-safe-effective-scientific-fraud
    • https://publichealthpolicyjournal.com/lawsuit-targeting-decades-old-journal-article-triggers-renewed-scrutiny-of-fraudulent-scientific-studies/
  3. CORROBORATEDCONF 0.80

    A re-analysis of GSK's original data shows that Paxil (paroxetine) was ineffective and harmful, particularly for suicidal ideation, when taken by adolescents, contrary to the original publication.

    — attributed to: r/science community, based on 'Restoring Study 329' publication

    • https://www.reddit.com/r/science/comments/3l8r8l/restoring_study_329_efficacy_and_harms_of/
    • https://www.researchgate.net/publication/49804124_Conflicted_Medical_Journals_and_the_Failure_of_Trust
  4. VERIFIEDCONF 0.90

    A lawsuit demands the retraction of the original Study 329 article due to alleged fraud.

    — attributed to: Paul D. Thacker (The Disinformation Chronicle)

    • https://tdefender.substack.com/p/lawsuit-retraction-journal-article-gsk-paxil-safe-effective-scientific-fraud
    • https://publichealthpolicyjournal.com/lawsuit-targeting-decades-old-journal-article-triggers-renewed_scrutiny-of-fraudulent-scientific-studies/
  5. SINGLE-SOURCECONF 0.70

    GlaxoSmithKline employed a ghostwriting program named Caspper, where doctors took credit for articles written by others.

    — attributed to: RxISK.org

    • https://rxisk.org/clinical-trial-fraud/
  6. VERIFIEDCONF 0.90

    Medical ghostwriting constitutes an act prohibited under the Racketeer Influenced and Corrupt Organizations Act (RICO).

    — attributed to: Fordham Law Review

    • http://fordhamlawreview.org/wp-content/uploads/2017/09/Minasi_October_v86.pdf
    • https://ir.lawnet.fordham.edu/cgi/viewcontent.cgi?article=5431&context=flr
  7. UNVERIFIABLECONF 0.00

    Former employees or contractors involved in the original Study 329 publication have come forward with information about ghostwriting disclosures.

    — attributed to: Investigation Lead (User Question)

TIMELINE

  • 1994SmithKline Beecham begins conducting Study 329. [src]
  • 1998Study 329 concludes. [src]
  • 2001Original Study 329 article published, claiming paroxetine is safe and effective for adolescent depression. [src]
  • 2015-09-24Re-analysis of Study 329 data published in BMJ, contradicting original findings and highlighting harms. [src]
  • 2017-09-25Fordham Law Review article suggests medical ghostwriting may constitute a RICO act. [src]
  • 2021-06-28RxISK.org alleges GlaxoSmithKline employed a ghostwriting program called Caspper. [src]
  • 2023-09Lawsuit filed demanding retraction of original Study 329 article. [src]

ENTITIES

  • ORG SmithKline Beecham — Pharmaceutical company that conducted Study 329
  • ORG GlaxoSmithKline (GSK) — Successor to SmithKline Beecham, implicated in ghostwriting allegations
  • ORG Paxil (Paroxetine) — Antidepressant drug, subject of Study 329
  • ORG Tofranil (Imipramine) — Antidepressant drug, comparator in Study 329
  • EVENT Study 329 — Clinical trial of paroxetine in adolescents
  • EVENT Caspper — Alleged ghostwriting program employed by GSK
  • ORG Racketeer Influenced and Corrupt Organizations Act (RICO) — Legal framework under which ghostwriting is alleged to be prohibited

OPEN QUESTIONS — PENDING LEADS

  • Are there any specific declassified internal GSK documents or court records that detail the 'Caspper' ghostwriting program and its participants?
  • Have any individuals listed as authors or contributors on the original Study 329 publication later commented on or disclosed details about ghostwriting involvement?
  • What are the names of the individuals or organizations that filed the lawsuit demanding retraction of the Study 329 article?
  • Have any government agencies (e.g., FDA, SEC) conducted investigations into the ghostwriting allegations surrounding Study 329, and what were their findings?
  • Are there any documented instances of former GSK employees or contractors providing testimony or affidavits in legal proceedings related to Study 329 ghostwriting?

EVIDENCE — CAPTURED SOURCES

  1. [WEB] http://fordhamlawreview.org/wp-content/uploads/2017/09/Minasi_October_v86.pdf [archived]
    25 Sept 2017 · This Note takes the stance that medical ghostwriting constitutes an act prohibited under the Racketeer Influenced and Corrupt Organizations Act.
  2. [WEB] https://www.wisnerbaum.com/prescription-drugs/paxil-suicide-lawsuit/gsk-clinical-trials-paxil-fraud/ [archived]
    Ghostwriting and Fraud in GSK Clinical Trials Between 1994 and 1998, SmithKline Beecham (now GlaxoSmithKline) conducted a clinical trial, Study 329, that compared Paxil to Tofranil (imipramine) and placebo in children and adolescents with major depression.
  3. [WEB] https://ir.lawnet.fordham.edu/cgi/viewcontent.cgi?article=5431&context=flr [archived]
    This Note takes the stance that medical ghostwriting constitutes an act prohibited under the Racketeer Influenced and Corrupt Organizations Act. (RICO) and ...
  4. [WEB] https://publichealthpolicyjournal.com/lawsuit-targeting-decades-old-journal-article-triggers-renewed-scrutiny-of-fraudulent-scientific-studies/ [archived]
    By Michael Nevradakis, Ph.D. A lawsuit demanding the retraction of a decades-old peer-reviewed article that claimed the antidepressant paroxetine, sold as Paxil, is safe and effective has put the issue of fraud in scientific and medical journals back in the spotlight, Paul D. Tha…
  5. [WEB] https://www.researchgate.net/publication/49804124_Conflicted_Medical_Journals_and_the_Failure_of_Trust
    The now-infamous Study 329 of paroxetine in adolescent depression was negative for efficacy on all eight protocol-specified outcomes and positive for harm, but ...
  6. [WEB] https://tdefender.substack.com/p/lawsuit-retraction-journal-article-gsk-paxil-safe-effective-scientific-fraud [archived]
    A lawsuit aiming to retract a 2001 article that falsely claimed the antidepressant paroxetine, or Paxil, is safe has renewed interest in cracking down on fraud in scientific and medical publishing.
  7. [WEB] https://rxisk.org/clinical-trial-fraud/
    28 Jun 2021 · GlaxoSmithKline employed a ghostwriting programme named Caspper in which doctors could take credit for medical journal articles written by the ...
  8. [WEB] https://en.wikipedia.org/wiki/Study_329 [archived]
    Study 329 was a clinical trial which was conducted in North America from 1994 to 1998 to study the efficacy of paroxetine, an SSRI anti-depressant, in treating 12- to 18-year-olds diagnosed with major depressive disorder.
  9. [REDDIT] https://www.reddit.com/r/zmarter/ [archived]
    The study was published in the Journal of ・ offer a novel explanation of the cognitive factors through which abusive leadership degrades employee performance ...
  10. [REDDIT] https://www.reddit.com/r/Gangstalking/comments/3m2m3r/what_happened_to_those_suicidal_in_study_329/
    /r/gangstalking is a subreddit that focuses upon presenting information about predatory gangstalking and also to exist as a community to organize as a group to spread awareness and education.
  11. [REDDIT] https://www.reddit.com/r/UnusedSubforMe/comments/q5gk6d/notes12/ [archived]
    10 Oct 2021 · Now to know is more than to believe, as to be dignified with the highest honour after being saved is a greater thing than being saved.
  12. [REDDIT] https://www.reddit.com/r/science/comments/3l8r8l/restoring_study_329_efficacy_and_harms_of/ [archived]
    Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence. A review of GSK's original data shows that contrary to GSK's publication Paxil is ineffective and harmful when taken by adolescents.
  13. [REDDIT] https://www.reddit.com/r/Documentaries/comments/75e77t/paxil_study_329_2011_the_study_that_hid_childrens/ [archived]
    Paxil Study 329 (2011) The study that hid children's suicides in order to extend the patent of a drug. The story revealed by an inquisitive journalist with no training.
  14. [REDDIT] https://www.reddit.com/r/careeradvice/comments/134dory/do_you_think_companies_keep_track_of_who/ [archived]
    Companies keep records on former employees and whether or not they are eligible for re-hire. If you left the company on good terms had have an excellent performance record then chances are you would be rehired.
  15. [REDDIT] https://www.reddit.com/r/ConflictOfInterest/comments/3prvpm/study_329_conflicts_of_interest/ [archived]
    1.3K subscribers in the ConflictOfInterest community. Research, news, analysis, resources, conflicts of interest, conflicts, external, real-world…
  16. [REDDIT] https://www.reddit.com/r/todayilearned/comments/9xy2pj/til_of_study_329_a_pharmaceutical_study_by_the/ [archived]
    TIL of Study 329: a pharmaceutical study by the manufacturer of Paxil. It concluded that the drug was effective in treating adolescent depression. Later, it was shown that even in low risk individuals, the group taking Paxil was actually more likely to attempt suicide. : r/todayi…

CROSS-REFERENCE

Study 329: Paroxetine Clinical Trial Data Suppression and Publication Bias — SHARES-EVENT (OUTGOING)STUDY 329: PAROXETINE CLI…Study 329: Allegations of Ghostwriting in Paroxetine Clinical TrialSTUDY 329: ALLEGATIONS OF G…THIS FILESHARES-EVENT